Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - adrenalintartrat - injektionsvæske, opløsning i fyldt pen - 300 mikrogram

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

alfasigma s.p.a. - methylthioniniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - adrenalin - injektionsvæske, opløsning - 0,3 mg/dosis

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

epione medicine aps - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multipelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - adrenalintartrat - injektionsvæske, opløsning i fyldt pen - 300 mikrogram